Skip to content

Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Usefulness of Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07261956
Enrollment
202
Registered
2025-12-03
Start date
2025-08-25
Completion date
2026-01-31
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia, Pulmonary Edema - Acute

Keywords

Pulmonary edema, Severe preeclampsia, B lines, Lung ultrasound

Brief summary

This research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a leading cause of maternal death and illness worldwide, often causing fluid buildup that can lead to a serious complication called pulmonary edema, especially after delivery. The study will be a prospective, longitudinal observational study with a diagnostic validation component. It will involve patients with a diagnosis of severe preeclampsia who meet specific inclusion criteria. Each participant will undergo a clinical exam and a lung ultrasound, which will assess eight zones of the lungs. The total number of B-lines-a sign of interstitial edema-will be documented. Data will be collected at three key times: upon admission, in the immediate postpartum period (within 24 hours of delivery), and 7-10 days postpartum. The results from the LUS will be compared to clinical signs like shortness of breath, rapid breathing, crackling sounds in the lungs, and oxygen saturation levels. The expected impact of this research is to provide evidence that LUS is a valuable, non-invasive, and accessible tool for the early detection of pulmonary congestion in patients with severe preeclampsia. This could lead to improved clinical decision-making and a reduction in maternal respiratory complications.

Interventions

DIAGNOSTIC_TESTLung ultrasound

Lung ultrasounf at three moments (at admission, before delivery and immediate post partum) to determine B Lines

Sponsors

Saint Thomas Hospital, Panama
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Preeclampsia with severe features. * Gestational age 24 weeks - 41 weeks.

Exclusion criteria

* Chronic lung disease. * Known heart disease. * Diagnosis of lung edema at admission * Body mass index \> 40 * Need for immediate delivery

Design outcomes

Primary

MeasureTime frameDescription
Lung Ultrasound evaluationOne evaluation at admission, another one just before delivery and a final one 24 hours after deliveryThree or more B Lines in at least two lung zones using lung ultrasound

Secondary

MeasureTime frameDescription
DyspneaReport of the symptom by the patient from admission for up to three daysSubjective sensation of difficulty breathing
TachypneaReport of the symptom from admission for up to three days.Respiratory rate above 20 breaths/min
Oxygen saturationReport of the value measured by a pulse oxymeter from admission for up to three daysOxygen saturation measured by pulse oxymeter

Countries

Panama

Contacts

Primary ContactAnna C Figueroa, MD
annacfigue@gmail.com+507 69494250
Backup ContactAdriana Martinz, MD
amartinzmd@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026